santa cruz biotechnology, inc.
SCBT Logo

Willkommen!        Produkt(e) im Warenkorb.     Bestellen

TARSL1 (S-13) Antikörper: sc-165652

 |  Datenblatt
  • goat polyclonal IgG, 200 µg/ml
  • epitope mapping near the C-terminus of TARSL1 of human origin
  • recommended for detection of TARSL1 of mouse, rat and human origin by WB, IF and ELISA; non cross-reactive with TARSL2
  • blocking peptide, sc-165652 P
 
Weitere TARS Antikörper ...
 
Bestellinformationen
Empfohlene Supportprodukte:
(Klicken Sie auf die gewünschte Anwendung um passenden Supportprodukte anzuzeigen.)
WB   IF  
 
Spezies Gen Gen ID Chromosomaler Locus mRNA (Isoform) Accession # Protein Accession # OMIM™ Nummer
Human TARS2 80222 1q21.2 NM_025150 Q9BW92
n/a
Maus Tars2 71807 3 F2.1 NM_001163617, NM_001163618, NM_001163619, NM_027931 Q3UQ84
n.n.
 
Währung auswählen

 Bestellinformationen
ProduktKatalog #MengePreisAnzahlKaufFavorit
TARSL1 (S-13) sc-165652 200 µg/ml $279
TARSL1 (S-13) P sc-165652 P
(peptide)
100 µg/0.5 ml $61

TARSL1 Background Information
TARSL1, also known as TARS2 (threonyl-tRNA synthetase 2, mitochondrial) or ThrRS (threonine--tRNA ligase), is a 718 amino acid mitochondrial matrix protein that belongs to the class-II aminoacyl-tRNA synthetase family. The gene encoding TARSL1 maps to human chromosome 1q21.3. Chromosome 1 is the largest human chromosome spanning approximately 260 million base pairs, 3,000 genes, and making up 8% of the human genome. The rare aging disease Hutchinson-Gilford progeria is associated with the LMNA gene located on chromosome 1. When defective, the LMNA gene product can build up in the nucleus and cause characteristic nuclear blebs. The MUTYH gene, also located on chromosome 1, is partially responsible for familial adenomatous polyposis. Stickler syndrome, Parkinsons, Gaucher disease and Usher syndrome are also associated with chromosome 1. A breakpoint has been identified in 1q which disrupts the DISC1 gene and is linked to schizophrenia. Aberrations in chromosome 1 are found in a variety of cancers including head and neck cancer, malignant melanoma and multiple myeloma.